View in EDS

Healthcare provider stigma toward patients with substance use disorders.

Saved in:
Bibliographic Details
Title: Healthcare provider stigma toward patients with substance use disorders.
Authors: Parish, Carrigan L., Feaster, Daniel J., Pollack, Harold A., Horigian, Viviana E., Wang, Xiaoming, Jacobs, Petra, Pereyra, Margaret R., Drymon, Christina, Allen, Elizabeth, Gooden, Lauren K., del Rio, Carlos, Metsch, Lisa R.
Source: Addiction. Oct2025, Vol. 120 Issue 10, p2005-2019. 15p.
Subjects: Substance abuse, Cocaine, Repeated measures design, Medical personnel, Research funding, Methamphetamine, Data analysis, Probability theory, Questionnaires, Statistical sampling, Planned behavior theory, Medical care, Descriptive statistics, Dentists, Heroin, Attitudes of medical personnel, Opioid analgesics, Statistics, Type 2 diabetes, Alcoholism, Data analysis software, Confidence intervals, Psychosocial factors, Social stigma, Drug abusers, Fentanyl, Social distancing
Geographic Terms: United States
Abstract: Background and aims: The overdose epidemic accounts for more than 89 000 deaths across the United States annually. Despite the availability of medications and therapies to treat substance use disorders (SUD), most people remain untreated. Stigma towards treating patients with SUD has been identified as a potential barrier to SUD treatment. This study aimed to quantify the prevalence and intensity of provider stigma towards patients with SUD, by substance use type and compared with other conditions, and its relationship to providers' clinical practices. Design: National probability sample survey (October 2020–October 2022). Setting: USA; online/paper questionnaire. Participants: Primary care (PCPs) and emergency medicine physicians (EMPs) and dentists randomly selected from the American Medical and Dental Associations. Data were collected from 1240 participants (Council of American Survey Research Organizations response rate 53.6%). Measurements The main outcome was self‐reported provider stigma towards people with SUD, assessed by the Medical Condition Regard Scale. Providers indicated their agreement with 11 statements concerning three SUD categories [opioids (OUD), stimulants, alcohol (AUD)], Type II diabetes, depressive disorder and HIV. Mixed models compared stigma levels across conditions and by clinician group. Clinicians were assessed about their screening, referral and treatment practices. Findings The lowest stigma rating was for diabetes (mean = 23.2; standard deviation = 6.5) and the highest for stimulant use disorders (mean = 36.3; standard deviation = 10.7). Stigma towards OUD was statistically significantly higher than AUD [effect size (ES) = 0.49, 95% confidence interval (CI) = (0.42–0.57), P < 0.001], while stigma towards stimulant use disorders was statistically significantly higher than OUD [ES = 0.11, 95% CI = (−0.04 to 0.19), P < 0.004]. EMPs had statistically significantly higher stigma scores than PCPs (P < 0.001), while PCPs reported significantly higher stigma scores than did dentists (P < 0.014). Lower stigma scores were associated with provision of SUD referrals [ES = −0.37, 95% CI = (−0.66 to −0.07)], providing medications for OUD [stigma scores: AUD (ES = ‐0.44, 95% CI = [−0.73 to −0.15]), OUD (ES = −1.26, 95% CI = [−1.55 to −0.97]) and stimulant use disorder (ES = −0.73, 95% CI = [−1.02 to −0.44])] and having available SUD consultation [stigma scores: AUD (ES = −0.48, 95% CI = [−0.67 to −0.28]), OUD (ES = −0.51, 95% CI = [−0.86 to −0.37]) and stimulant use disorder (ES = −0.59, 95% CI = [−0.78 to −0.39])]. Conclusions: Among US primary care and emergency medicine physician workforces, provider stigma towards substance use disorders appears to be higher than for opioid, stimulant and alcohol use disorders and negatively associated with providers' clinical practices. [ABSTRACT FROM AUTHOR]
Copyright of Addiction is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 187948810
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Healthcare provider stigma toward patients with substance use disorders.
– Name: Author
  Label: Authors
  Group: Au
  Data: &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Parish%2C+Carrigan+L%2E%22&quot;&gt;Parish, Carrigan L.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Feaster%2C+Daniel+J%2E%22&quot;&gt;Feaster, Daniel J.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Pollack%2C+Harold+A%2E%22&quot;&gt;Pollack, Harold A.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Horigian%2C+Viviana+E%2E%22&quot;&gt;Horigian, Viviana E.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Wang%2C+Xiaoming%22&quot;&gt;Wang, Xiaoming&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Jacobs%2C+Petra%22&quot;&gt;Jacobs, Petra&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Pereyra%2C+Margaret+R%2E%22&quot;&gt;Pereyra, Margaret R.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Drymon%2C+Christina%22&quot;&gt;Drymon, Christina&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Allen%2C+Elizabeth%22&quot;&gt;Allen, Elizabeth&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Gooden%2C+Lauren+K%2E%22&quot;&gt;Gooden, Lauren K.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22del+Rio%2C+Carlos%22&quot;&gt;del Rio, Carlos&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Metsch%2C+Lisa+R%2E%22&quot;&gt;Metsch, Lisa R.&lt;/searchLink&gt;
– Name: TitleSource
  Label: Source
  Group: Src
  Data: &lt;searchLink fieldCode=&quot;JN&quot; term=&quot;%22Addiction%22&quot;&gt;Addiction&lt;/searchLink&gt;. Oct2025, Vol. 120 Issue 10, p2005-2019. 15p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Substance+abuse%22&quot;&gt;Substance abuse&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Cocaine%22&quot;&gt;Cocaine&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Repeated+measures+design%22&quot;&gt;Repeated measures design&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Medical+personnel%22&quot;&gt;Medical personnel&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Research+funding%22&quot;&gt;Research funding&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Methamphetamine%22&quot;&gt;Methamphetamine&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Data+analysis%22&quot;&gt;Data analysis&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Probability+theory%22&quot;&gt;Probability theory&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Questionnaires%22&quot;&gt;Questionnaires&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Statistical+sampling%22&quot;&gt;Statistical sampling&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Planned+behavior+theory%22&quot;&gt;Planned behavior theory&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Medical+care%22&quot;&gt;Medical care&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Descriptive+statistics%22&quot;&gt;Descriptive statistics&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Dentists%22&quot;&gt;Dentists&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Heroin%22&quot;&gt;Heroin&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Attitudes+of+medical+personnel%22&quot;&gt;Attitudes of medical personnel&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Opioid+analgesics%22&quot;&gt;Opioid analgesics&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Statistics%22&quot;&gt;Statistics&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Type+2+diabetes%22&quot;&gt;Type 2 diabetes&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Alcoholism%22&quot;&gt;Alcoholism&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Data+analysis+software%22&quot;&gt;Data analysis software&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Confidence+intervals%22&quot;&gt;Confidence intervals&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Psychosocial+factors%22&quot;&gt;Psychosocial factors&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Social+stigma%22&quot;&gt;Social stigma&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Drug+abusers%22&quot;&gt;Drug abusers&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Fentanyl%22&quot;&gt;Fentanyl&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Social+distancing%22&quot;&gt;Social distancing&lt;/searchLink&gt;
– Name: SubjectGeographic
  Label: Geographic Terms
  Group: Su
  Data: &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22United+States%22&quot;&gt;United States&lt;/searchLink&gt;
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Background and aims: The overdose epidemic accounts for more than 89 000 deaths across the United States annually. Despite the availability of medications and therapies to treat substance use disorders (SUD), most people remain untreated. Stigma towards treating patients with SUD has been identified as a potential barrier to SUD treatment. This study aimed to quantify the prevalence and intensity of provider stigma towards patients with SUD, by substance use type and compared with other conditions, and its relationship to providers&#39; clinical practices. Design: National probability sample survey (October 2020–October 2022). Setting: USA; online/paper questionnaire. Participants: Primary care (PCPs) and emergency medicine physicians (EMPs) and dentists randomly selected from the American Medical and Dental Associations. Data were collected from 1240 participants (Council of American Survey Research Organizations response rate 53.6%). Measurements The main outcome was self‐reported provider stigma towards people with SUD, assessed by the Medical Condition Regard Scale. Providers indicated their agreement with 11 statements concerning three SUD categories [opioids (OUD), stimulants, alcohol (AUD)], Type II diabetes, depressive disorder and HIV. Mixed models compared stigma levels across conditions and by clinician group. Clinicians were assessed about their screening, referral and treatment practices. Findings The lowest stigma rating was for diabetes (mean = 23.2; standard deviation = 6.5) and the highest for stimulant use disorders (mean = 36.3; standard deviation = 10.7). Stigma towards OUD was statistically significantly higher than AUD [effect size (ES) = 0.49, 95% confidence interval (CI) = (0.42–0.57), P &lt; 0.001], while stigma towards stimulant use disorders was statistically significantly higher than OUD [ES = 0.11, 95% CI = (−0.04 to 0.19), P &lt; 0.004]. EMPs had statistically significantly higher stigma scores than PCPs (P &lt; 0.001), while PCPs reported significantly higher stigma scores than did dentists (P &lt; 0.014). Lower stigma scores were associated with provision of SUD referrals [ES = −0.37, 95% CI = (−0.66 to −0.07)], providing medications for OUD [stigma scores: AUD (ES = ‐0.44, 95% CI = [−0.73 to −0.15]), OUD (ES = −1.26, 95% CI = [−1.55 to −0.97]) and stimulant use disorder (ES = −0.73, 95% CI = [−1.02 to −0.44])] and having available SUD consultation [stigma scores: AUD (ES = −0.48, 95% CI = [−0.67 to −0.28]), OUD (ES = −0.51, 95% CI = [−0.86 to −0.37]) and stimulant use disorder (ES = −0.59, 95% CI = [−0.78 to −0.39])]. Conclusions: Among US primary care and emergency medicine physician workforces, provider stigma towards substance use disorders appears to be higher than for opioid, stimulant and alcohol use disorders and negatively associated with providers&#39; clinical practices. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: &lt;i&gt;Copyright of Addiction is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder&#39;s express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.&lt;/i&gt; (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=187948810
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/add.70122
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 15
        StartPage: 2005
    Subjects:
      – SubjectFull: Substance abuse
        Type: general
      – SubjectFull: Cocaine
        Type: general
      – SubjectFull: Repeated measures design
        Type: general
      – SubjectFull: Medical personnel
        Type: general
      – SubjectFull: Research funding
        Type: general
      – SubjectFull: Methamphetamine
        Type: general
      – SubjectFull: Data analysis
        Type: general
      – SubjectFull: Probability theory
        Type: general
      – SubjectFull: Questionnaires
        Type: general
      – SubjectFull: Statistical sampling
        Type: general
      – SubjectFull: Planned behavior theory
        Type: general
      – SubjectFull: Medical care
        Type: general
      – SubjectFull: Descriptive statistics
        Type: general
      – SubjectFull: Dentists
        Type: general
      – SubjectFull: Heroin
        Type: general
      – SubjectFull: Attitudes of medical personnel
        Type: general
      – SubjectFull: Opioid analgesics
        Type: general
      – SubjectFull: Statistics
        Type: general
      – SubjectFull: Type 2 diabetes
        Type: general
      – SubjectFull: Alcoholism
        Type: general
      – SubjectFull: Data analysis software
        Type: general
      – SubjectFull: Confidence intervals
        Type: general
      – SubjectFull: Psychosocial factors
        Type: general
      – SubjectFull: Social stigma
        Type: general
      – SubjectFull: Drug abusers
        Type: general
      – SubjectFull: Fentanyl
        Type: general
      – SubjectFull: Social distancing
        Type: general
      – SubjectFull: United States
        Type: general
    Titles:
      – TitleFull: Healthcare provider stigma toward patients with substance use disorders.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Parish, Carrigan L.
      – PersonEntity:
          Name:
            NameFull: Feaster, Daniel J.
      – PersonEntity:
          Name:
            NameFull: Pollack, Harold A.
      – PersonEntity:
          Name:
            NameFull: Horigian, Viviana E.
      – PersonEntity:
          Name:
            NameFull: Wang, Xiaoming
      – PersonEntity:
          Name:
            NameFull: Jacobs, Petra
      – PersonEntity:
          Name:
            NameFull: Pereyra, Margaret R.
      – PersonEntity:
          Name:
            NameFull: Drymon, Christina
      – PersonEntity:
          Name:
            NameFull: Allen, Elizabeth
      – PersonEntity:
          Name:
            NameFull: Gooden, Lauren K.
      – PersonEntity:
          Name:
            NameFull: del Rio, Carlos
      – PersonEntity:
          Name:
            NameFull: Metsch, Lisa R.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: Oct2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 09652140
          Numbering:
            – Type: volume
              Value: 120
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Addiction
              Type: main
ResultId 1